LYRALyra Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of Lyra Therapeutics, Inc. against SIC 3841 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LYRAThis | $878567#12 | — | — | 2.2x#6 | -74.1%#13 | 69.0%#5 | -7794.5%#13 | — | — | — | -93.9%#9 | — |
| ADGM | $11M#9 | — | 1.9x#4 | — | — | — | — | -438.1%#9 | -139.5%#8 | — | — | — |
| AEMD | $1M#11 | — | 0.3x#1 | — | -100.0%#14 | 46.6%#7 | — | -146.4%#7 | — | — | — | — |
| ALRTF | — | — | — | — | 978.8%#1 | -38.9%#11 | 16719.9%#1 | — | — | — | — | — |
| ALUR | $10M#10 | — | — | 0.7x#2 | -52.6%#10 | -299.5%#13 | -198.0%#10 | — | — | 2#9 | — | — |
| ALURD | — | — | — | — | -52.6%#10 | -299.5%#13 | -198.0%#10 | — | — | 2#9 | — | — |
| ALURW | — | — | — | — | -52.6%#10 | -299.5%#13 | -198.0%#10 | — | — | 2#9 | — | — |
| AMIX | $49M#7 | — | 8.4x#8 | — | — | -46.5%#12 | — | -283.5%#8 | -1150.9%#9 | — | -84.1%#8 | — |
| ANGO | $592M#4 | — | 3.5x#6 | 1.8x#5 | 9.5%#7 | -8.1%#9 | -12.5%#8 | -21.5%#5 | -16.5%#5 | 4#7 | 57.0%#2 | — |
| ANIK | $204M#5 | — | 1.5x#3 | 1.8x#3 | -5.9%#9 | 80.4%#3 | -9.8%#5 | -8.0%#4 | -8.8%#4 | 4#7 | 37.0%#3 | — |
| AORT | $1.3B#3 | 108.1x#1 | 2.9x#5 | 3.0x#7 | 13.6%#5 | 173.1%#1 | 7.6%#2 | 2.2%#1 | 3.7%#1 | 7#1 | -14.0%#5 | 0.3%#1 |
| APYX | $161M#6 | — | 12.6x#9 | 3.1x#8 | 9.9%#6 | 52.2%#6 | -12.2%#7 | -87.4%#6 | -25.1%#7 | 6#3 | 96.4%#1 | — |
| ARAY | $29M#8 | — | 0.7x#2 | 0.1x#1 | 2.7%#8 | 89.8%#2 | 1.7%#3 | -3.8%#3 | 0.0%#2 | 6#3 | -82.2%#7 | — |
| ATEC | $1.4B#2 | — | — | 1.8x#4 | 25.0%#3 | 11.6%#8 | -10.7%#6 | — | -19.2%#6 | 6#3 | -14.3%#6 | — |
| ATRC | $2.0B#1 | 189.4x#2 | 3.9x#7 | 3.8x#9 | 14.9%#4 | 74.4%#4 | -1.8%#4 | -2.2%#2 | -2.3%#3 | 7#1 | 25.1%#4 | — |
| AURX | — | — | — | — | 142.7%#2 | -8.1%#10 | -76.0%#9 | — | — | 5#6 | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 3841). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-07-29.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice